Kevin Leach, Ph.D.

Toxicologist, Non-Clinical Development

Shire Human Genetic Therapies

Kevin Leach, Ph.D. is a Toxicologist within Non-Clinical Development at Shire Human Genetic Therapies. Dr. Leach obtained his Ph.D. in Biochemistry from the Medical College of Virginia. Since 2010, Kevin has been a Diplomate of the American Board of Toxicology.

Global Outsourcing
Sunday, January 01, 2012
Global outsourcing of pre-clinical studies is an increasingly important aspect of drug discovery and development. In order to extract the most value out of an outsourced pre-clinical project abroad there are several strategic decisions that require ...